SUMMARY We describe a 3 year old girl with the typical clinical features of the X linked recessive condition, Hunter's disease. The diagnosis was confirmed by the pattern of urinary excretion of glycosaminoglycans and the absence of iduronate sulphatase activity in her fibroblasts. She also had an apparently balanced reciprocal chromosomal translocation 46XX,t(X:5) with the X breakpoint being between q26 and q27. Pedigree analysis, and the normal iduronate sulphatase activity in the mother's fibroblasts, serum, and hair roots indicate that the affected child represents a new mutation. Since the parents' karyotypes are normal, it seems that the translocation disrupted the iduronate sulphatase gene itself, thus mapping this to Xq26-27 for the first time. The severe clinical features, not expected in a girl, may be explained by non-random X inactivation.
Hunter's disease (mucopolysaccharidosis type II)1 is an X linked recessive disorder caused by deficiency of the lysosomal enzyme iduronate sulphatase. Affected boys accumulate dermatan sulphate and heparan sulphate in their tissues, causing coarsening of facial features, joint contractures, and in many instances shortness of stature, deafness, cardiac involvement, and intellectual deterioration. Heterozygous females do not usually show any clinical features of the disease. We report a girl who has the full clinical and biochemical features of Hunter's disease, and in addition has an apparently balanced X:5 chromosomal translocation. Neither parent has the translocation and the mother is not heterozygous for the Hunter gene. The proposed interpretation of these data is that the translocation 'breakpoint' disrupted the Hunter (Fig. 2) . The diagnosis was confirmed by total deficiency of iduronate sulphatase in cultured skin fibroblasts from the patient. Her mother's fibroblasts possessed a normal activity (Table) . Arylsulphatase A and B activities in the patient's fibroblasts and leucocytes were normal, thus excluding a diagnosis of multiple sulphatase deficiency; normal activities were also found for oc iduronidase, a mannosidase and ( galactosidase (in leucocytes); and ( glucuronidase and aM glucosaminidase (in plasma).
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Cytogenetic studies in the patient and her parents Chromosome analysis on cultured skin fibroblasts from the patient showed a seemingly balanced reciprocal translocation between chromosomes X and 5. (Fig. 3) . The breakpoint on the X chromosome was estimated as being between q26 and q27. Her karyotype may be described as 46,XX,t(X;5) (q2?7;q3?1) or (q2?6;q3 ?2). Both her parents had entirely normal karyotypes.
Family studies and mother's carrier status The patient's mother (I2) has two healthy sons (II1 and II) aged 7 years and 5 years, respectively, and a healthy brother (Is). (Fig. 4) (Fig. 4) . ' It is extremely unlikely that a de novo chromosomal translocation involving the X chromosome and a new mutation at a known X linked gene locus should occur in the same person by coincidence. The most plausible explanation is that the translocation happened to disrupt the Hunter gene itself; thus mapping that locus to Xq26-7-the translocation breakpoint. More detailed cytogenetic studies aimed at defining the breakpoint more precisely are underway.
If the above explanation is correct, then it is still necessary to explain why the patient has the full clinical picture of Hunter's disease, when she is only heterozygous for the Hunter gene and still has one normal allele. Female heterozygotes usually show no clinical features of the disease. The reason for the full clinical picture in our patient is almost certainly that her normal X chromosome which carries the normal allele at the Hunter locus, is the inactive X chromosome in all her cells, instead of the expected proportion of about 50 %. This non-random X inactivation in X autosome translocations is well described.5 Although the exact mechanism is not clear, it is as if the attachment to an autosome ensures that the translocated segments of the X chromosome are active, and this in turn results in inactivation of the intact normal X chromosome.
A phenomenon similar to the present case has been reported in more than five separate female patients with the full clinical picture of the X linked recessive disorder Duchenne muscular dystrophy.R 7 All had X autosome translocations, and although different autosomes were affected, the breakpoint on the X chromosome was always at the same band, p21, suggesting that this is the site for the Duchenne muscular dystrophy gene locus. This mapping of the Duchenne muscular dystrophy gene locus has recently been confirmed by linkage analysis using a group.bmj.com on October 14, 2017 -Published by http://adc.bmj.com/ Downloaded from DNA probe (lambda RC8) which maps to Xp2l/ Xp223.8 DNA probes for various regions of the long arm of the X chromosome are becoming available and linkage analysis using these should allow us to confirm that the Hunter gene locus is indeed located at Xq26-7.
